Contract Specifications

Instrument Type Underlying Expiry Date Option Type Strike Price Market Lot

Price Information

Last Price Today's Change Underlying value
 0.00   [0]  0.00
 
Open  0.00
Prev Close  0.00
Today's Range  0.00 - 0.00
Average Price  0.00
Buy(size)  0.00
Sell(size)  0.00

Turnover Open Interest Information

Volume Turnover Open Interest Change in OI %Change in OI
 0.00  0.00  0.00   [0.00]   [0]
FIIs trend in derivatives
Instruments Buy[Rs.Cr] Sell[Rs.Cr] Net Positions [Rs.Cr] Contracts ['000s] OI Value[Rs.Cr]
Index Futures 1,369.63 2,197.61 [827.98] 258.78 10,518.55
Index Options 10,515.80 9,607.38 908.42 1,493.47 60,433.08
Stock Futures 1,699.20 2,458.38 [759.18] 1,293.08 48,186.30
Stock Options 1,669.68 1,653.66 16.02 60.64 2,238.82
News

IndusInd Bank drops after Q2FY19 earnings

India Infoline News Service Oct-15-2018

The company's net profit which has improved by 4.5% yoy to Rs920cr was below consensus estimates.

TV18 Broadcast stock zooms after strong Q2FY19 numbers

India Infoline News Service Oct-15-2018

Its revenue stood at Rs1,198cr vs. Rs1,084cr in the corresponding quarter last year.

Hero MotoCorp (HMCL) Q2FY19E result expectation

India Infoline News Service Oct-15-2018

The companys move towards higher capacity motorcycles (200cc bikes and 125cc scooters) will lead to further improvement in ASP in subsequent quarters.

HUL slips 3% despite PAT rising 19.5% in Q2FY19

India Infoline News Service Oct-15-2018

All segments of the company reported double-digit revenue growth and EBIT margin expansion.

Wholesale inflation up 5.13% in September

India Infoline News Service Oct-15-2018

The rate of inflation based on WPI Food Index consisting of Food Articles from Primary Articles group and Food Products from Manufactured Products group increased from -2.25% in August 2018 to 0.14% in September 2018.

Oil rises as Saudi Arabia vows to hit back against any sanctions

India Infoline News Service Oct-15-2018

Futures in New York climbed as much as 1.9% after posting the biggest weekly loss since May.

 
Indian Equities News
Latest

Dr. Reddy’s gets final approval for gAggrenox

India Infoline News Service / 14:50, Oct 15, 2018

Aggrenox and its generics are estimated to have sales of ~$183mn MAT in the US for the twelve months ending August 2018. Dr. Reddy's will be competing against Sun Pharma, Teva, Sandoz, etc.